Lactobacillus Rhamnosus
Probiotic ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
One of the most researched probiotic strains for gut and immune health.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Lactobacillus Rhamnosus is a probiotic most often used for gut health, immune support, diarrhea prevention. NutriStack rates the overall evidence as strong. A typical adult dose is 10-20 billion CFU daily, commonly taken as lgg strain (lactobacillus rhamnosus gg is patented strain). This profile indexes 19 sources.
The bottom line
Evidence rating strong. Most-documented uses: gut health, immune support, diarrhea prevention. 19 sources indexed (2001–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Adheres to intestinal mucosa, produces bacteriocins against pathogens, strengthens gut barrier by upregulating mucin and tight junction proteins, and modulates Th1/Th2 immune balance.15,18
Dosing & protocol.
Take with a meal or up to 30 minutes before a meal for better probiotic survival3
What it actually costs.
Real-world pricing across three quality tiers. Assumes Lactobacillus rhamnosus GG.
Assumes 10-20 billion CFU/day. Vendor basis: Culturelle/iHerb, Vitacost, Amazon marketplace, and practitioner probiotic products; strain-specific LGG costs more than generic blends. Updated 2026-05-28.
The same dose, as food.
How much you'd eat to match a supplemental dose.
Strain and CFU counts are product-specific; generic fermented foods may not contain L. rhamnosus.
Full safety detail.
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
8- 1Effect of Probiotics Lactobacillus rhamnosus and Lactobacillus plantarum on Caries and Periodontal Diseases: A Systematic ReviewPMIDD'Agostino S, Valentini G, Iarussi F et al. · Dentistry journal · 2024
D'Agostino S, Valentini G, Iarussi F et al.. Effect of Probiotics Lactobacillus rhamnosus and Lactobacillus plantarum on Caries and Periodontal Diseases: A Systematic Review. Dentistry journal. 2024
- 2Lactobacillus rhamnosus GG for Cow's Milk Allergy in Children: A Systematic Review and Meta-AnalysisPMIDTan W, Zhou Z, Li W et al. · Frontiers in pediatrics · 2021
Tan W, Zhou Z, Li W et al.. Lactobacillus rhamnosus GG for Cow's Milk Allergy in Children: A Systematic Review and Meta-Analysis. Frontiers in pediatrics. 2021
- 3Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysisPMIDLi YT et al. · World J Gastroenterol · 2019
LGG administration notably reduced diarrhea duration, with more effective results at high dose of at least 10^10 CFU per day
- 4Lactobacillus rhamnosus GG in the Primary Prevention of Eczema in Children: A Systematic Review and Meta-AnalysisPMIDSzajewska H et al. · Nutrients · 2018
Meta-analysis demonstrated statistically significant reductions in atopic eczema at timeframes of 2 years and 6-7 years with perinatal use of L. rhamnosus
- 5Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adultsPMIDSzajewska H et al. · Aliment Pharmacol Ther · 2015
LGG is effective in preventing antibiotic-associated diarrhea in children and adults treated with antibiotics, with significant benefit particularly in children
- 6Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhoodPMIDHorvath A, Dziechciarz P, Szajewska H · Alimentary pharmacology & therapeutics · 2011
Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Alimentary pharmacology & therapeutics. 2011
- 7Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic reviewPMIDHawrelak JA, Whitten DL, Myers SP · Digestion · 2005
Hawrelak JA, Whitten DL, Myers SP. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion. 2005
- 8Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in children: a meta-analysisSource linkedPMIDSzajewska H, Kotowska M, Mrukowicz JZ et al. · J Pediatr · 2001
Randomized controlled trials
4- 9Lactobacillus rhamnosus GG to Reduce Necrotising Enterocolitis, Sepsis, and Mortality in Very Low Birth Weight Infants: A Randomized Controlled TrialPMIDShah S, Kaul A, Pandey P et al. · Indian pediatrics · 2026
Shah S, Kaul A, Pandey P et al.. Lactobacillus rhamnosus GG to Reduce Necrotising Enterocolitis, Sepsis, and Mortality in Very Low Birth Weight Infants: A Randomized Controlled Trial. Indian pediatrics. 2026
- 10Oral Lacticaseibacillus rhamnosus GG Exposure During Pregnancy and Effects on Maternal Inflammatory Response-A Blinded, Pilot Randomized, Placebo-Controlled StudyPMIDNordqvist M, Hallingström M, Nerén A et al. · American journal of reproductive immunology (New York, N.Y. : 1989) · 2025
Nordqvist M, Hallingström M, Nerén A et al.. Oral Lacticaseibacillus rhamnosus GG Exposure During Pregnancy and Effects on Maternal Inflammatory Response-A Blinded, Pilot Randomized, Placebo-Controlled Study. American journal of reproductive immunology (New York, N.Y. : 1989). 2025
- 11The Efficacy of a Mix of Probiotics (Limosilactobacillus reuteri LMG P-27481 and Lacticaseibacillus rhamnosus GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Clostridium difficile Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized TrialPMIDSaviano A, Petruzziello C, Cancro C et al. · Microorganisms · 2024
Saviano A, Petruzziello C, Cancro C et al.. The Efficacy of a Mix of Probiotics (Limosilactobacillus reuteri LMG P-27481 and Lacticaseibacillus rhamnosus GG ATCC 53103) in Preventing Antibiotic-Associated Diarrhea and Clostridium difficile Infection in Hospitalized Patients: Single-Center, Open-Label, Randomized Trial. Microorganisms. 2024
- 12A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonizationPMIDRauseo AM, Hink T, Reske KA et al. · Infection control and hospital epidemiology · 2022
Rauseo AM, Hink T, Reske KA et al.. A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization. Infection control and hospital epidemiology. 2022
Reviews & position papers
3- 13Lactobacillus Bacteremia and Probiotics: A ReviewPMIDKullar R et al. · Microorganisms · 2023
Review summarizes Lactobacillus bacteremia associated with probiotic use and high-risk clinical contexts.
- 14Thirty Years of Lactobacillus rhamnosus GG: A ReviewPMIDCapurso L · J Clin Gastroenterol · 2019
Comprehensive review of one of the most researched probiotic strains, documenting evidence for gut health, immune support, diarrhea prevention, and atopic dermatitis
- 15Towards a better understanding of Lactobacillus rhamnosus GG--host interactionsPMIDSegers ME et al. · Microb Cell Fact · 2014
LGG adheres to intestinal mucosa, produces postbiotics that protect gut barrier function, strengthens tight junctions (ZO-1, claudin-1), and modulates immune response
Observational studies
2- 16Bacteraemia caused by Lactobacillus rhamnosus given as a probiotic in a patient with a central venous catheter: a WGS case reportPMIDRubin IMC, Stevnsborg L, Mollerup S et al. · Infection Prevention in Practice · 2022
Whole genome sequencing linked L. rhamnosus bacteremia to probiotic use in a patient with a central venous catheter.
- 17Probiotic related Lactobacillus rhamnosus endocarditis in a patient with liver cirrhosisPMIDNaqvi SSB, Nagendra V, Hofmeyr A · IDCases · 2018
Case report supports caution with L. rhamnosus probiotic use in cirrhosis and endocarditis-risk contexts.
Mechanistic & preclinical
1- 18Lactobacillus rhamnosus GG supernatant promotes intestinal mucin production through regulating 5-HT4R and gut microbiotaPMIDWang J et al. · Food Funct · 2022
LGG can enhance goblet cell expression and mucin barrier formation, correcting deficient MUC2 expression through 5-HT4R regulation and gut microbiota modulation
Reference material
1Common questions.
Quick answers about Lactobacillus Rhamnosus, drawn from the data on this page.
What is Lactobacillus Rhamnosus?
One of the most researched probiotic strains for gut and immune health.
What is Lactobacillus Rhamnosus used for?
Commonly cited benefits of Lactobacillus Rhamnosus include: Gut health; Immune support; Diarrhea prevention; Atopic dermatitis. NutriStack rates the overall evidence as strong.
What is a typical dose of Lactobacillus Rhamnosus?
A typical adult dose of Lactobacillus Rhamnosus is 10-20 billion CFU daily. The commonly recommended form is LGG strain (Lactobacillus rhamnosus GG is patented strain). These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Lactobacillus Rhamnosus?
Reported side effects include bloating initially, gas, very rarely bacteremia in immunocompromised. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Lactobacillus Rhamnosus?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Lactobacillus Rhamnosus in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.